Tisseel S/D Lösung für Gewebekleber; Lösung für Gewebekleber Belgium - German - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

tisseel s/d lösung für gewebekleber; lösung für gewebekleber

baxter - human-fibrinogen; faktor xiii; human-thrombin; aprotinin; calcium-chlorid dihydrat - lösung für gewebekleber; lösung für gewebekleber - 10 ml - human-fibrinogen ; faktor xiii ; human-thrombin ; aprotinin ; calcium-chlorid dihydrat - combinations

Ayvakyt European Union - German - EMA (European Medicines Agency)

ayvakyt

blueprint medicines (netherlands) b.v. - avapritinib - gastrointestinale stromatumoren - andere antineoplastische wirkstoffe, die protein-kinase-inhibitoren - ayvakyt is indicated as monotherapy for the treatment of adult patients with unresectable or metastatic gastrointestinal stromal tumours (gist) harbouring the platelet-derived growth factor receptor alpha (pdgfra) d842v mutation.

Iasocholine 1 GBq/ml Injektionslösung Belgium - German - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

iasocholine 1 gbq/ml injektionslösung

iason - fluorocholine (f-18) - injektionslösung - 1 gbq/ml - fluorocholine (f-18) - fluoromethylcholine (18f)

CARDIOXANE 500 mg, Pulver zur Herstellung einer Infusionslösung Germany - German - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

cardioxane 500 mg, pulver zur herstellung einer infusionslösung

clinigen healthcare b.v. (8181225) - dexrazoxan - pulver zur herstellung einer infusionslösung - teil 1 - pulver zur herstellung einer infusionslösung; dexrazoxan (26073) 500 milligramm

Sutent European Union - German - EMA (European Medicines Agency)

sutent

pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastische mittel - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.